Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Seckl

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Hematology/Oncology Clinics of North America|September 25, 2024
Future Directions for Gestational Trophoblastic DiseaseEhsan Ghorani, Michael J Seckl
Future Oncology (London, England)|December 15, 2010
Genetics of gestational trophoblastic neoplasia: an update for the clinicianConstantine Alifrangis, Michael J Seckl
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 13, 2021
Progress to international harmonisation of care and future developmentsMichael J Seckl, Ehsan Ghorani
Journal of Gynecologic Oncology|April 20, 2022
Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTNEhsan Ghorani, Michael J Seckl
Gynecologic Oncology|September 3, 2005
The role of repeat uterine evacuation in trophoblast diseasePhilip Savage, Michael J Seckl
Current Opinion in Oncology|September 1, 2007
Gestational trophoblastic neoplasia management: an updateSarah Ngan, Michael J Seckl
Gynecologic and Obstetric Investigation|October 12, 2023
From National to International Collaboration in Gestational Trophoblastic Disease: Hurdles and PossibilitiesFrancois Golfier, Michael J Seckl
Molecular and Cellular Endocrinology|October 31, 2006
Discrepancies between commercially available immunoassays in the detection of tumour-derived hCGHugh Mitchell, Michael J Seckl
The Journal of Reproductive Medicine|July 15, 2010
Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directionsNeil J Sebire, Michael J Seckl
Frontiers in Oncology|July 31, 2013
S6K2: The Neglected S6 Kinase Family MemberOlivier E Pardo, Michael J Seckl
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Hematology/Oncology Clinics of North America|September 25, 2024
Future Directions for Gestational Trophoblastic DiseaseEhsan Ghorani, Michael J Seckl
Future Oncology (London, England)|December 15, 2010
Genetics of gestational trophoblastic neoplasia: an update for the clinicianConstantine Alifrangis, Michael J Seckl
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 13, 2021
Progress to international harmonisation of care and future developmentsMichael J Seckl, Ehsan Ghorani
Journal of Gynecologic Oncology|April 20, 2022
Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTNEhsan Ghorani, Michael J Seckl
Gynecologic Oncology|September 3, 2005
The role of repeat uterine evacuation in trophoblast diseasePhilip Savage, Michael J Seckl
Current Opinion in Oncology|September 1, 2007
Gestational trophoblastic neoplasia management: an updateSarah Ngan, Michael J Seckl
Gynecologic and Obstetric Investigation|October 12, 2023
From National to International Collaboration in Gestational Trophoblastic Disease: Hurdles and PossibilitiesFrancois Golfier, Michael J Seckl
Molecular and Cellular Endocrinology|October 31, 2006
Discrepancies between commercially available immunoassays in the detection of tumour-derived hCGHugh Mitchell, Michael J Seckl
The Journal of Reproductive Medicine|July 15, 2010
Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directionsNeil J Sebire, Michael J Seckl
Frontiers in Oncology|July 31, 2013
S6K2: The Neglected S6 Kinase Family MemberOlivier E Pardo, Michael J Seckl
Pageof 16